ArticleThe Journal of pharmacology and experimental therapeutics2014

Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.

Hassan Issafras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.